These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1821803)
1. Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase. Sirawaraporn W; Edman JC; Santi DV Protein Expr Purif; 1991; 2(5-6):313-6. PubMed ID: 1821803 [TBL] [Abstract][Full Text] [Related]
2. Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase. Ma L; Kovacs JA Antimicrob Agents Chemother; 2000 Nov; 44(11):3092-6. PubMed ID: 11036028 [TBL] [Abstract][Full Text] [Related]
3. Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme. Delves CJ; Ballantine SP; Tansik RL; Baccanari DP; Stammers DK Protein Expr Purif; 1993 Feb; 4(1):16-23. PubMed ID: 8425104 [TBL] [Abstract][Full Text] [Related]
4. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. Edman JC; Edman U; Cao M; Lundgren B; Kovacs JA; Santi DV Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8625-9. PubMed ID: 2682653 [TBL] [Abstract][Full Text] [Related]
6. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein. Yu PL; Zhao J; Yu M; Reid R; Santi DV Protein Expr Purif; 1996 Aug; 8(1):23-7. PubMed ID: 8812831 [TBL] [Abstract][Full Text] [Related]
7. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii. Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582 [TBL] [Abstract][Full Text] [Related]
8. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Tahar R; de Pécoulas PE; Basco LK; Chiadmi M; Mazabraud A Mol Biochem Parasitol; 2001 Apr; 113(2):241-9. PubMed ID: 11295178 [TBL] [Abstract][Full Text] [Related]
9. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates. Margosiak SA; Appleman JR; Santi DV; Blakley RL Arch Biochem Biophys; 1993 Sep; 305(2):499-508. PubMed ID: 8373187 [TBL] [Abstract][Full Text] [Related]
10. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434 [TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and characterization of Cryptococcus neoformans dihydrofolate reductase. Sirawaraporn W; Cao M; Santi DV; Edman JC J Biol Chem; 1993 Apr; 268(12):8888-92. PubMed ID: 8473332 [TBL] [Abstract][Full Text] [Related]
12. Soluble expression in Escherichia coli, one-step purification, and characterization of Chinese hamster dihydrofolate reductase. Fan YX; Wang B; Jing GZ Protein Expr Purif; 1997 Mar; 9(2):246-52. PubMed ID: 9056490 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim. Rosowsky A; Forsch RA; Queener SF J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Bartlett MS; Shaw M; Navaran P; Smith JW; Queener SF Antimicrob Agents Chemother; 1995 Nov; 39(11):2436-41. PubMed ID: 8585722 [TBL] [Abstract][Full Text] [Related]
15. Characterization of dihydrofolate reductase of Pneumocystis carinii and Toxoplasma gondii. Kovacs JA; Allegra CJ; Masur H Exp Parasitol; 1990 Jul; 71(1):60-8. PubMed ID: 2354716 [TBL] [Abstract][Full Text] [Related]
16. Purification and properties of Escherichia coli dihydrofolate reductase. Baccanari D; Phillips A; Smith S; Sinski D; Burchall J Biochemistry; 1975 Dec; 14(24):5267-73. PubMed ID: 46 [TBL] [Abstract][Full Text] [Related]
17. The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. Gene synthesis, expression, and anti-folate-resistant mutants. Sirawaraporn W; Prapunwattana P; Sirawaraporn R; Yuthavong Y; Santi DV J Biol Chem; 1993 Oct; 268(29):21637-44. PubMed ID: 8408015 [TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of human-derived Pneumocystis jirovecii dihydrofolate reductase expressed in Sf21 insect cells and in Escherichia coli. Cody V; Chisum K; Pope C; Queener SF Protein Expr Purif; 2005 Apr; 40(2):417-23. PubMed ID: 15766885 [TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of recombinant Pneumocystis carinii thymidylate synthase. Santi DV; Edman U; Minkin S; Greene PJ Protein Expr Purif; 1991; 2(5-6):350-4. PubMed ID: 1821808 [TBL] [Abstract][Full Text] [Related]
20. Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase. Ma L; Jia Q; Kovacs JA Antimicrob Agents Chemother; 2002 Sep; 46(9):3101-3. PubMed ID: 12183283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]